These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2042993)

  • 1. Raised concentrations of von Willebrand factor antigen in systemic sclerosis.
    Blann AD; Illingworth KJ; Jayson MI
    Ann Rheum Dis; 1991 May; 50(5):337-8. PubMed ID: 2042993
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease.
    Greaves M; Malia RG; Milford Ward A; Moult J; Holt CM; Lindsey N; Hughes P; Goodfield M; Rowell NR
    Br J Rheumatol; 1988 Aug; 27(4):281-5. PubMed ID: 3136816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?
    Matucci-Cerinic M; Pignone A; Lotti T; Spillantini G; Curradi C; Leoncini G; Iannone F; Falcini F; Cagnoni M
    J Rheumatol; 1990 Mar; 17(3):328-30. PubMed ID: 2159071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement.
    Matucci-Cerinic M; Pignone A; Iannone F; Lotti T; Pesciullesi E; Spillantini G; Falcini F; Cagnoni M
    Respir Med; 1990 Jul; 84(4):283-7. PubMed ID: 2173047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor: increased levels are related to poor prognosis in systemic sclerosis and not to tissue autoantibodies.
    Blann AD; Sheeran TP; Emery P
    Br J Biomed Sci; 1997 Mar; 54(1):5-9. PubMed ID: 9167302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII A-chain in neoplastic proliferation of megakaryoblasts--a comparison with von Willebrand factor antigen.
    Nakazawa M; Ninomiya H; Nagasawa T; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1246-53. PubMed ID: 3500566
    [No Abstract]   [Full Text] [Related]  

  • 8. von Willebrand factor in upper gastrointestinal tract inflammation.
    Blann AD
    Gut; 1993 Feb; 34(2):288. PubMed ID: 8432488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factor VIII (von Willebrand antigen) in patients with acquired thrombocytopathies].
    Genova V; Baleva M; Nikolov K
    Vutr Boles; 1987; 26(2):82-5. PubMed ID: 3111097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay for von Willebrand factor antigen using a monoclonal antibody.
    Inoue K; Mazda T; Tobe T; Tomita M
    Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2550-4. PubMed ID: 3490315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor (author's transl)].
    Fukui H; Okuda T; Takase T; Mikami S; Yoshioka A; Fujimura Y; Yoshioka K
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):897-907. PubMed ID: 310619
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor-VIII-related antigen and vasculitis.
    Lancet; 1988 Jul; 2(8604):227-8. PubMed ID: 2899710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of a hemorrhagic syndrome in severe von Willebrand disease in the presence of circulating anti-von-Willebrand-factor antibody].
    Monteagudo J; López Guillermo A; Castillo R
    Med Clin (Barc); 1988 May; 91(1):28-30. PubMed ID: 3139944
    [No Abstract]   [Full Text] [Related]  

  • 14. A new automated method for von Willebrand factor antigen measurement using latex particles.
    Veyradier A; Fressinaud E; Sigaud M; Wolf M; Meyer D
    Thromb Haemost; 1999 Feb; 81(2):320-1. PubMed ID: 10064018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Von Willebrand factor multimers in systemic scleroderma].
    Valsecchi R; Cainelli T; Perticucci E; Gotti E; Viganò GB; Remuzzi G; Naldi L
    G Ital Dermatol Venereol; 1989 May; 124(5):193-6. PubMed ID: 2620918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunoradiometric assay for von Willebrand factor antigen to assess angiogenesis.
    Mourad MM; Giddings J; Marks R; Barton SP; Baverstock J
    Br J Dermatol; 1990 Jul; 123(1):21-8. PubMed ID: 1697187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of von Willebrand factor antigen, multimer structure and ristocetin cofactor activities].
    Goto S; Ichikawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():607-10. PubMed ID: 10543191
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.
    Malia RG; Greaves M; Rowlands LM; Lawrence AC; Hume A; Rowell NR; Moult J; Holt CM; Lindsey N; Hughes P
    Clin Exp Immunol; 1988 Sep; 73(3):456-60. PubMed ID: 2974767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical associations of C-reactive protein in systemic sclerosis].
    Alekperov RT; Baranov AA; Abaĭtova NE
    Ter Arkh; 2006; 78(6):30-5. PubMed ID: 16881360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High von Willebrand factor antigen levels are associated with increased mortality in connective tissue diseases.
    Blann AD; Emery P
    Br J Rheumatol; 1992 Mar; 31(3):211-2. PubMed ID: 1540796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.